June 4, 2021 ~ TrialSite News Scripps Research Study Showcases Big Promise for COVID-19 Repurposed Drugs: But the System’s Broken & New Leadership in HHS Necessary Scripps Research announced study results indicating 90 existing drugs or drug candidates possessing...
Fact-Checking the Fact-Checkers Yet Again: This Time on the Potential Association of Ivermectin to the Dramatic Decrease in COVID-19 Cases in India
June 1, 2021 ~ TrialSite News Fact-Checking the Fact-Checkers Yet Again: This Time on the Potential Association of Ivermectin to the Dramatic Decrease in COVID-19 Cases in India A TrialSite community member recently submitted an entry associated with a purported “fact...
Indian Giant Reliance Industries Developing Niclosamide-based Drug Targeting COVID-19
June 1, 2021 ~ Trial Site News Indian Giant Reliance Industries Developing Niclosamide-based Drug Targeting COVID-19 Much like Ivermectin, Niclosamide is in the anthelmintic family of drugs, and recently, Indian mega-corporation Reliance Industries Ltd....
The Emerging COVID-19 Therapy Market for Early Onset, Non-Hospitalized Patients: Three Segments to Watch
The Emerging COVID-19 Therapy Market for Early Onset, Non-Hospitalized Patients: Three Segments to Watch Three parallel worlds, segmented by socioeconomics, culture, and politics unfold during this pandemic, divided into what can be considered tier 1, tier 2, and tier...
UK Clinical Trial Involving France-based MedinCell’s Ivermectin-based Product Proves Safe in Clinical Trial
https://www.covidstrategies.org/uk-clinical-trial-involving-france-based-medincells-ivermectin-based-product-proves-safe-in-clinical-trial/https://trialsitenews.com/uk-clinical-trial-involving-france-based-medincells-Ivermectin-based-product-proves-safe-in-clinical-trial/?utm_source=Contextly&utm_medium=ChannelEmail&utm_campaign=Ivermectin&utm_content=Notification Originally published by: TrialSiteNews...
Pharmacy Magazine UK Touts the Ivermectin’s Positive Potential Targeting COVID-19
https://www.covidstrategies.org/pharmacy-magazine-uk-touts-the-ivermectins-positive-potential-targeting-covid-19/https://trialsitenews.com/pharmacy-magazine-uk-touts-the-Ivermectins-positive-potential-targeting-covid-19/?utm_source=Contextly&utm_medium=ChannelEmail&utm_campaign=Ivermectin&utm_content=Notification Originally published by: TrialSiteNews Author: TrialSiteNews...
Randomized Double-Blinded Clinical Trial at Sheba Medical Center: Ivermectin Materially Reduces COVID-19 Viral Shedding
https://www.covidstrategies.org/randomized-double-blinded-clinical-trial-at-sheba-medical-center-ivermectin-materially-reduces-covid-19-viral-shedding/https://trialsitenews.com/randomized-double-blinded-clinical-trial-at-sheba-medical-center-Ivermectin-materially-reduces-covid-19-viral-shedding/ Originally published by: trialSiteNews Author: staff Date: 2/13/2021 Categories: Integrative...
Bill and Melinda Gates Fund Global Ivermectin & Fluvoxamine Clinical Trial Targeting COVID-19: Together COVID-19 Trial
https://www.covidstrategies.org/bill-and-melinda-gates-fund-global-ivermectin-fluvoxamine-clinical-trial-targeting-covid-19-together-covid-19-trial/https://trialsitenews.com/bill-and-melinda-gates-fund-global-Ivermectin-fluvoxamine-clinical-trial-targeting-covid-19-together-covid-19-trial/ Originally published by: trialSiteNews Author: staff Date: 2/11/2021 Categories: Integrative Therapies,Treatment
A Letter to NIH and Dr. Anthony Fauci. Is Anybody Home?
By Mary Beth Pfeiffer Dr. David Chesler is knocking at the door of the mighty U.S. National Institutes of Health. He has something urgent to share. Dr. Chesler is a geriatric specialist at seven Virginia nursing homes. Early in the pandemic, he read studies showing...